{
    "2018-10-30": [
        [
            {
                "time": "2018-11-05",
                "original_text": "机构评级精选：控量挺价增速换挡 五粮液评级获上调",
                "features": {
                    "keywords": [
                        "五粮液",
                        "评级",
                        "上调",
                        "控量挺价"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "【中银医药】华兰生物2018三季报点评：血制品见底回升，四价流感疫苗开始放量",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "三季报",
                        "血制品",
                        "流感疫苗",
                        "放量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "财通证券：华兰生物买入评级",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "买入评级",
                        "财通证券"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "华兰生物早盘封跌停 成交额6.17亿元封单8724手",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "跌停",
                        "成交额",
                        "封单"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "华兰生物：血制品保持稳定增长 预计疫苗业务开始盈利",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "稳定增长",
                        "疫苗业务",
                        "盈利"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-03",
                "original_text": "华兰生物:业绩延续高增长,血制品盈利能力逐步恢复",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "业绩",
                        "高增长",
                        "血制品",
                        "盈利能力",
                        "恢复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}